Chinese tariffs could raise price of prescriptions in US: 3 things to know

President Donald Trump's decision to increase tariffs for select Chinese imports by 25 percent may lead to higher prescription drug prices in the U.S., according to The Hill.

Here are three things to know.

1. President Trump's list of imports that may be hit with the increased tariffs include ingredients used to produce insulin, epinephrine and antidepressants.

2. According to the FDA, China is one of the largest suppliers of ingredients for domestic prescription drug manufacturers.

3. "We are concerned that the proposed tariffs may lead to increased costs of manufacturing for generics and biosimilars and thus higher prescription drug prices for patients in the U.S.," the Association for Accessible Medicines said in a statement.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars